Glucagon-like peptide-1 (GLP-1), an incretin hormone secreted primarily from the intestinal
L-cells in response to meals, modulates nutrient homeostasis via actions exerted in multiple …

In normal physiology, glucagon from pancreatic alpha cells plays an important role in
maintaining glucose homeostasis via its regulatory effect on hepatic glucose production …

Abstract Glucagon like peptide-1 (GLP-1) is an incretin hormone that is in the pipeline for
type 2 diabetes mellitus (T2DM) therapy. However, oral administration of GLP-1 is hindered …

Therapies targeting the action of incretin hormones have been under close scrutiny in recent
years. The incretin effect has been defined as postprandial enhancement of insulin secretion …

Aims To assess efficacy and safety of lixisenatide once-daily versus placebo in Type 2
diabetes mellitus (T2DM) patients inadequately controlled on sulfonylurea (SU)±metformin …

Insulin resistance and the metabolic syndrome are associated with fasting and postprandial
dyslipidemia. This involves the hepatic and intestinal overproduction of very low density …

'Suioh', a sweet potato (Ipomoea batatas L.) cultivar developed in Japan, has edible leaves
and stems. The sweet potato leaves contain polyphenols such as caffeoylquinic acid (CQA) …

Glucose homeostasis is precisely regulated by glucagon and insulin, which are released by
pancreatic α-and β-cells, respectively. While β-cells have been the focus of intense …

La diabetes es un trastorno metabólico que se ha incrementado en Latinoamérica y
Venezuela en la última década. Ejerce una influencia considerable en la morbimortalidad …

Introduction: The dramatic rise in the prevalence of obesity and type 2 diabetes mellitus
(T2DM) is associated with increased mortality, morbidity as well as public health care …